Records containing: Myelodysplastic Syndromes
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-05-25A Prospective, Multicenter, Randomized, Open-Label Phase 2, Parallel, Dose Ranging Multidose Study of Thrombosomes® vs Liquid Stored Platelets (LSP) in Bleeding Thrombocytopenic Patients
-
CLINICAL_TRIALS study record update · 2023-05-24Phase 1/Phase 2 Study of IMM01 Combined With Azacitidine in Patients With AML and MDS
-
CLINICAL_TRIALS study record update · 2023-05-24Prospective Non-randomized Multi-center Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood
-
CLINICAL_TRIALS study record update · 2023-05-18A Phase 3, Multicenter, Randomized, Open-Label Study of Guadecitabine (SGI-110) Versus Treatment Choice in Adults With Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML) Previously Treated With Hypomethylating Agents
-
CLINICAL_TRIALS study record update · 2023-05-10A Phase II Trial of Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Unrelated Donors in Patients With Advanced Hematologic Malignancies and Hematological Disorders
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-05-10Allogeneic Stem Cell Transplant With a Novel Conditioning Therapy Using Helical Tomotherapy, Melphalan, and Fludarabine in Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2023-05-06Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors (COSMOS)
-
CLINICAL_TRIALS study record update · 2023-04-13Allogeneic Stem Cell Transplantation for Patients With Hematological Malignancies Using Multiple Unrelated Cord Blood Units
-
CLINICAL_TRIALS study record update · 2023-03-16A Phase II Prospective Randomized Trial of Donor T-memory Cells (CD45RA Depleted) Infusion for Prevention of Infections After Allogeneic TcRαβ/CD19-depleted Hematopoietic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2023-03-13Effectiveness of DNA Hypomethylating Agents and Lenalidomide in Elderly Patients With Myeloid Malignancies in the United States
-
CLINICAL_TRIALS study record update · 2023-03-01Faecal Microbiota Transplantation for Prevention of Graft-versus-host Sisease After Allogeneic Stem Cell Transplantation for Haematological Malignancies
-
CLINICAL_TRIALS study record update · 2023-02-16A Phase Ib Study Evaluating the Safety and Efficacy of IBI188 in Combination With Azacitidine in Subjects With Newly Diagnosed Higher Risk Myelodysplastic Syndrome
-
CLINICAL_TRIALS study record update · 2023-02-08A Phase 1, Non-Randomized, Open-Label/Phase 2, Randomized, Blinded Study of ProTmune™ (ex Vivo Programmed Mobilized Peripheral Blood Cells) Versus Non-Programmed Mobilized Peripheral Blood Cells for Allogeneic Hematopoietic Cell Transplantation in Adult Subjects With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2023-02-02Treatment of Poor Prognosis Acute Myeloid Leukemia and Blastic Crisis Chronic Myelogenous Leukemia With Mylotarg, High-Dose Cytarabine, Mitozantrone and Ethyol AML/CML 2000-06.
-
CLINICAL_TRIALS study record update · 2023-01-23Adoptive Immunotherapy in Patients With Relapsed Hematological Malignancy: Effect of Duration and Intensity of Early GVHD Prophylaxis on Long-Term Clinical Outcomes
-
CLINICAL_TRIALS study record update · 2023-01-23A Phase I Pilot Study of Abaloparatide + Bevacizumab in Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2023-01-04Effects of Prebiotics on Gut Microbiome in Patients Undergoing Stem Cell Transplants
-
CLINICAL_TRIALS study record update · 2022-12-27A Phase I/II Dose Escalation Trial of Clofarabine, in Addition to Melphalan and Thiotepa as Myeloablative Regimen Followed by an Allogeneic Unmodified Hematopoietic Stem Cell Transplant From HLA-Compatible Related or Unrelated Donors for the Treatment of High Risk and/or Advanced Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2022-12-21A Pilot Study of a Novel Sequential Treatment Utilizing CPX-351 as Salvage Chemotherapy Followed by Allogeneic Stem-Cell Transplantation (SCT) Utilizing a Haplo-cord Graft for Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome
-
CLINICAL_TRIALS study record update · 2022-12-01A Multicentric Phase I/II Study of Jaktinib Hydrochloride Tablets in Combination With Azacitidine for Injection in Patients With Myelodysplastic Syndromes(MDS) With Myelofibrosis(MF) or MDS/Myeloproliferative Neoplasms With MF
-
CLINICAL_TRIALS study record update · 2022-11-28Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker
-
CLINICAL_TRIALS study record update · 2022-11-23Allogeneic Hematopoietic Progenitor Cell Transplantation From Unrelated Donors
-
CLINICAL_TRIALS study record update · 2022-11-22Analysis of Risk in MDS Over Time - Comparison of Treated vs Untreated Patients
-
CLINICAL_TRIALS study record update · 2022-11-21Early and Low Dose Deferasirox (3.5 mg/kg FCT) to Suppress NTBI and LPI as Early Intervention to Prevent Tissue Iron Overload in Lower Risk MDS
-
CLINICAL_TRIALS study record update · 2022-11-15A Phase 1, Open-Label, Multicenter, Dose-Escalation Study of PRT1419 in Patients With Relapsed/Refractory Hematologic Malignancies